These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32221841)

  • 21. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect.
    McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB
    Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test.
    Kotagale NR; Tripathi SJ; Aglawe MM; Chopde CT; Umekar MJ; Taksande BG
    Pharmacol Biochem Behav; 2013 Jun; 107():42-7. PubMed ID: 23583442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.
    Kawai H; Iwadate R; Ishibashi T; Kudo N; Kawashima Y; Mitsumoto A
    Chronobiol Int; 2019 Sep; 36(9):1194-1207. PubMed ID: 31198056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice.
    Yu HL; Deng XQ; Li YJ; Li YC; Quan ZS; Sun XY
    Pharmacol Rep; 2011; 63(3):834-9. PubMed ID: 21857095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel antagonists of 5-HT
    Partyka A; Jastrzębska-Więsek M; Antkiewicz-Michaluk L; Michaluk J; Wąsik A; Canale V; Zajdel P; Kołaczkowski M; Wesołowska A
    Behav Brain Res; 2019 Feb; 359():9-16. PubMed ID: 30312638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural toxicity of antidepressants with particular reference to moclobemide.
    Hindmarch I; Kerr J
    Psychopharmacology (Berl); 1992; 106 Suppl():S49-55. PubMed ID: 1546141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent.
    Ferris RM; Maxwell RA; Cooper BR; Soroko FE
    Adv Biochem Psychopharmacol; 1982; 31():277-86. PubMed ID: 6282058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice.
    de Angelis L
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):379-83. PubMed ID: 8878071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The β4 nicotinic receptor subunit modulates the chronic antidepressant effect mediated by bupropion.
    Radhakrishnan R; Santamaría A; Escobar L; Arias HR
    Neurosci Lett; 2013 Oct; 555():68-72. PubMed ID: 23981664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of bupropion augmentation of minocycline in the treatment of depression.
    Bendale M; DSouza SR; Addepalli V; Kale PP
    Acta Neurobiol Exp (Wars); 2019; 79(2):217-224. PubMed ID: 31342957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice.
    Shearman LP; Rosko KM; Fleischer R; Wang J; Xu S; Tong XS; Rocha BA
    Behav Pharmacol; 2003 Dec; 14(8):573-82. PubMed ID: 14665974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.
    Bourin M; Chenu F; Ripoll N; David DJ
    Behav Brain Res; 2005 Nov; 164(2):266-9. PubMed ID: 16087251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice.
    Kale PP; Addepalli V
    Pharmacol Biochem Behav; 2014 Sep; 124():238-44. PubMed ID: 24933334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil, a phosphodiesterase type 5 inhibitor, enhances the activity of two atypical antidepressant drugs, mianserin and tianeptine, in the forced swim test in mice.
    Socała K; Nieoczym D; Wyska E; Poleszak E; Wlaź P
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):121-6. PubMed ID: 22406168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.
    Kruk-Slomka M; Budzynska B; Slomka T; Banaszkiewicz I; Biala G
    Neurotox Res; 2016 Nov; 30(4):658-676. PubMed ID: 27577742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo characterization of T-794, a novel reversible inhibitor of monoamine oxidase-A, as an antidepressant with a wide safety margin.
    Kato M; Katayama T; Iwata H; Yamamura M; Matsuoka Y; Narita H
    J Pharmacol Exp Ther; 1998 Mar; 284(3):983-90. PubMed ID: 9495858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants for smoking cessation.
    Hughes JR; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000031. PubMed ID: 17253443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous inhibition of catechol-O-methyltransferase and monoamine oxidase A: effects on hemodynamics and catecholamine metabolism in healthy volunteers.
    Illi A; Sundberg S; Ojala-Karlsson P; Scheinin M; Gordin A
    Clin Pharmacol Ther; 1996 Apr; 59(4):450-7. PubMed ID: 8612391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.